APA (7th ed.) Citation

Camps, C., Sarries, C., Roig, B., Javier Sánchez, J., Queralt, C., Sancho, E., . . . Rosell, R. (2003). Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients. Clinical lung cancer, 4(4), 237-241. https://doi.org/10.3816/CLC.2003.n.004

Chicago Style (17th ed.) Citation

Camps, Carlos, Carmen Sarries, Bárbara Roig, José Javier Sánchez, Cristina Queralt, Eva Sancho, Natividad Martinez, Miguel Tarón, and Rafael Rosell. "Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients." Clinical Lung Cancer 4, no. 4 (2003): 237-241. https://doi.org/10.3816/CLC.2003.n.004.

MLA (9th ed.) Citation

Camps, Carlos, et al. "Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine/Cisplatin–Treated Advanced Non–Small-Cell Lung Cancer Patients." Clinical Lung Cancer, vol. 4, no. 4, 2003, pp. 237-241, https://doi.org/10.3816/CLC.2003.n.004.